Journal
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
Volume 52, Issue 12, Pages 1341-1359Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jaac.2013.09.015
Keywords
tic disorders; Tourette's disorder; treatment; Practice Parameter
Categories
Funding
- NIH/NIMH
- CDC
- Otsuka Pharmaceuticals
- NARSAD
- IOCDF
- Ortho-McNeil Janssen Pharmaceuticals
- Shire Pharmaceuticals
- Pfizer, Inc.
- Indevus Pharmaceuticals
- Tourette Syndrome Association
- International Obsessive Compulsive Disorder Foundation
- National Alliance for Research on Schizophrenia and Depression
- University of South Florida Research Foundation, Inc.
- Centers for Disease Control
- National Institutes of Health
- Ortho-McNeil Neurologics
- Transportation Security Administration
- GlaxoSmithKline
- Forest Research Institute
- Merck/Schering-Plough
- Supernus
- Bristol-Myers Squibb
- AstraZeneca
- Boehringer-Ingelheim
Ask authors/readers for more resources
Tic disorders, including Tourette's disorder, present with a wide range of symptom severity and associated comorbidity. This Practice Parameter reviews the evidence from research and clinical experience in the evaluation and treatment of pediatric tic disorders. Recommendations are provided for a comprehensive evaluation to include common comorbid disorders and for a hierarchical approach to multimodal interventions.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
